Suppr超能文献

阴阳 1 通过调节 和 来抑制扩张型心肌病和心肌纤维化。

Yin Yang 1 Suppresses Dilated Cardiomyopathy and Cardiac Fibrosis Through Regulation of and .

机构信息

From the Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (C.Y.T., J.X.W., P.S.C., H.T., D.L., W.C., J.J.).

Cardiovascular Research Institute, National University Health System, Centre for Translational Medicine, Singapore (C.Y.T., J.X.W., P.S.C., H.T., D.L., W.C., M.A.-J., J.W.W., R.S.F., J.J.).

出版信息

Circ Res. 2019 Oct 11;125(9):834-846. doi: 10.1161/CIRCRESAHA.119.314794. Epub 2019 Sep 9.

Abstract

RATIONALE

Pathogenic variations in the lamin gene () cause familial dilated cardiomyopathy (DCM). insufficiency caused by pathogenic variants is believed to be the basic mechanism underpinning -related DCM.

OBJECTIVE

To assess whether silencing of cardiac causes DCM and investigate the role of Yin Yang 1 () in suppressing DCM.

METHODS AND RESULTS

We developed a DCM mouse model induced by cardiac-specific short hairpin RNA. Silencing of cardiac induced DCM with associated cardiac fibrosis and inflammation. We demonstrated that upregulation of suppressed DCM and cardiac fibrosis by inducing expression and preventing upregulation of . Knockdown of upregulated attenuated the suppressive effect of on DCM and cardiac fibrosis. However, upregulation of alone was not sufficient to suppress DCM and cardiac fibrosis. Importantly, upregulation of together with silencing significantly suppressed DCM and cardiac fibrosis. Mechanistically, upregulation of regulated and reporter activities and modulated and gene expression in cardiomyocytes. Downregulation of inhibited TGF-β (transforming growth factor-β)/Smad signaling in DCM hearts. Regulation of both and further suppressed TGFβ/Smad signaling. In addition, co-modulation of and reduced CD3+ T cell numbers in DCM hearts.

CONCLUSIONS

Our findings demonstrate that upregulation of or co-modulation of and offer novel therapeutic strategies for the treatment of DCM caused by insufficiency.

摘要

背景

层粘连蛋白基因 () 的致病变异可引起家族性扩张型心肌病 (DCM)。致病性变异导致的 不足被认为是 -相关 DCM 的基本机制。

目的

评估心脏 沉默是否会导致 DCM,并研究阴阳 1 () 在抑制 DCM 中的作用。

方法和结果

我们开发了一种心脏特异性短发夹 RNA 诱导的 DCM 小鼠模型。心脏 沉默可诱导 DCM 伴心肌纤维化和炎症。我们证明上调 可通过诱导 表达和防止 上调来抑制 DCM 和心肌纤维化。下调上调可减弱 对 DCM 和心肌纤维化的抑制作用。然而,上调 本身不足以抑制 DCM 和心肌纤维化。重要的是,上调 与 沉默一起可显著抑制 DCM 和心肌纤维化。机制上,上调 调节心肌细胞中的 和 报告基因活性,并调节 和 基因表达。下调 可抑制 DCM 心脏中的 TGF-β(转化生长因子-β)/Smad 信号。 和 进一步调节 TGFβ/Smad 信号。此外, 与 的共同调节可减少 DCM 心脏中的 CD3+T 细胞数量。

结论

我们的研究结果表明,上调 或 与 的共同调节为治疗由 不足引起的 DCM 提供了新的治疗策略。

相似文献

引用本文的文献

4
Cardiomyopathy: pathogenesis and therapeutic interventions.心肌病:发病机制与治疗干预措施
MedComm (2020). 2024 Oct 25;5(11):e772. doi: 10.1002/mco2.772. eCollection 2024 Nov.

本文引用的文献

3
CTGF/CCN2 is an autocrine regulator of cardiac fibrosis.CTGF/CCN2 是心脏纤维化的自分泌调节剂。
J Mol Cell Cardiol. 2018 Aug;121:205-211. doi: 10.1016/j.yjmcc.2018.07.130. Epub 2018 Jul 21.
4
Gene therapy comes of age.基因治疗走向成熟。
Science. 2018 Jan 12;359(6372). doi: 10.1126/science.aan4672.
7
Dilated cardiomyopathy.扩张型心肌病。
Lancet. 2017 Jul 22;390(10092):400-414. doi: 10.1016/S0140-6736(16)31713-5. Epub 2017 Feb 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验